Menu
Commercial Products

Commercial Products

RedHill’s U.S. commercial operations, headquartered in Raleigh, NC, include a gastrointestinal-focused sales force. RedHill has assembled an experienced specialty GI commercial team, with a proven track-record, to lead its U.S. commercial operations. 

RedHill promotes several specialty gastrointestinal products in the U.S. territories and plans to launch Talicia® in Q1/2020.

Promoted products

Aemcolo® (rifamycin) – prescription drug

Click here to access the full Prescribing Information or product website 

Donnatal® (Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, Scopolamine Hydrobromide) - prescription drug

Click here to access the full Prescribing Information or product website

EnteraGam® (serum-derived bovine immunoglobulin/protein isolate, SBI) - medical food

Click here to access the Product Information or product website

Mytesi® (crofelemer 125 mg delayed-release tablets) – prescription drug

Click here to access the full Prescribing Information or product website 

Planned launch

Talicia® (omeprazole, amoxicillin and rifabutin) – prescription drug

Click here to access the full Prescribing Information

 

 

 

RedHill's Development Pipeline